YD Bio (NASDAQ:YDES) Shares Up 2.8% – Here’s Why

YD Bio Limited (NASDAQ:YDES)’s stock price shot up 2.8% during mid-day trading on Monday . The company traded as high as $5.46 and last traded at $5.6150. 6,427 shares traded hands during trading, a decline of 75% from the average session volume of 25,456 shares. The stock had previously closed at $5.46.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on YDES. Wall Street Zen upgraded YD Bio from a “sell” rating to a “hold” rating in a report on Saturday, February 28th. Weiss Ratings restated a “sell (d+)” rating on shares of YD Bio in a report on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

YD Bio Stock Performance

The stock has a 50 day moving average price of $7.11.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in YD Bio stock. Geode Capital Management LLC increased its position in YD Bio Limited (NASDAQ:YDES) by 10.0% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 58,363 shares of the biotechnology company’s stock after purchasing an additional 5,292 shares during the quarter. Geode Capital Management LLC owned approximately 0.08% of YD Bio worth $711,000 as of its most recent filing with the Securities & Exchange Commission.

About YD Bio

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.